MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2024 International Congress

    Catalan MSA Registry (CMSAR): Applying new Clinical Criteria and Biomarkers for Increasing Diagnostic Accuracy, is New Better?

    A. Pérez-Soriano, C. Painous, J. Pérez, M. Fernandez, Y. Compta, Consortium, MJ. Martí (Barcelona, Spain)

    Objective: To reassess the CMSAR and determine if new criteria and new biomarkers can enhance diagnostic accuracy. Background: The CMSAR, conducted between 2015 and 2019,…
  • 2024 International Congress

    Accuracy of Clinical features for Substantia Nigra Hypopigmentation and Cortical Lewy Body Presence in the Oldest-Old: The 90+ Study

    R. Rajmohan, Z. Al-Darsani, N. Phielipp, T. Montine, M. Corrada, C. Kawas (Orange, USA)

    Objective: To improve clinical diagnostic accuracy of Lewy Body Dementia (LBD), we assessed if frontal release signs are a useful screening tool for cortical Lewy…
  • 2024 International Congress

    Mixed Brain Pathology in Neurodegenerative Parkinsonism and Dementia

    K. Mensikova, L. Tuckova, D. Hrabos, A. Jawad, P. Kanovsky (Olomouc, Czech Republic)

    Objective: To assess the presence of mixed neurodegenerative pathology and its proportion in the prospective cohort of patients treated for any phenotype of neurodegenerative parkinsonism,…
  • 2024 International Congress

    Cognitive Side Effects to Initial Levodopa Exposure as a “Red Flag”: A Retrospective Study

    A. Huang, A. Wise, V. Shanker (New York, USA)

    Objective: To assess if presence of cognitive side effects during an initial levodopa trial suggests the ultimate diagnosis of atypical Parkinson (APD) vs Parkinson disease…
  • 2024 International Congress

    Brainstem Monoaminergic Degeneration, Cognition, and Autonomic Symptom Progression in Early Parkinson’s Disease

    KA. Woo, SY. Kim, HY. Choi, JH. Shin, HJ. Kim (Seoul, Republic of Korea)

    Objective: In this study, we aimed to investigate the association between brainstem monoaminergic nuclear degeneration, particularly the serotonergic raphe and noradrenergic locus coeruleus, and cognitive…
  • 2024 International Congress

    Can Simple Home Based Exercises Reduce the Fear of Falling in Parkinson Disorders?

    R. Neupane, P. Kukkle (Bangalore, India)

    Objective: To examine the potential benefit of a simple home-based gait and balance training on fear of fall in patients with Parkinson’s (PwP). Background: PwP…
  • 2024 International Congress

    Preclinical Studies: Investigating Serum-Based Exosomal miRNAs in Prodromal Drug-Induced Parkinson’s Disease

    M. Ahmad (Hyderabad, India)

    Objective: This work aims to elucidate the identification of homologs of miRNAs in a pronormal stage of Parkinson`s disease. Background: Parkinson's disease (PD) is defined…
  • 2024 International Congress

    Parkinsonism after Internal Globus Pallidus Deep Brain Stimulation in Dystonia

    T. Lampreia, D. Martins, L. Guedes, M. Mendonça, M. Coelho (Loures, Portugal)

    Objective: To evaluate the frequency and predictors of parkinsonism after GPi-DBS in dystonia; to describe the clinical characteristics and stimulation changes performed to improve parkinsonism.…
  • 2024 International Congress

    Parkinsonism in combined Fragile X and XYY Syndromes: A Case Report

    M. Carta, B. Balint (Zurich, Switzerland)

    Objective: We describe an unusual case of parkinsonism in a 45-year-old male with Fragile X syndrome and XYY syndrome. Background: Fragile X syndrome (FXS) is…
  • 2024 International Congress

    GBA Mutation Profile in Parkinson’s Disease: Insights from a Movement Disorders Center in Brazil

    F. Rolim, S. Lima, A. Verde, P. Matos, A. Marinho, F. Carvalho (Fortaleza, Brazil)

    Objective: To identify the prevalence of pathogenic variants of the GBA1 mutation among patients with parkinsonism who have undergone genetic testing. Background: GBA gene encodes…
  • 1
  • 2
  • 3
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #25116 (not found)
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley